(Q35186821)

7 August 2017

title

Use of tumour marker immunoreactivity to identify primary site of metastatic cancer (English)

1 reference

7 August 2017

5

Ellis IO

1 reference

7 August 2017

Gamble AR

1

1 reference

7 August 2017

Bell JA

series ordinal

2

1 reference

7 August 2017

Ronan JE

series ordinal

3

1 reference

7 August 2017

Pearson D

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

7 August 2017

1 reference

7 August 2017

volume

306

1 reference

7 August 2017

issue

6873

1 reference

7 August 2017

page(s)

295-298

1 reference

The management of patients with adenocarcinoma and poorly differentiated carcinoma of unknown primary site.

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1676878

Monoclonal antibodies in the diagnosis and treatment of carcinoma of the breast.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1676878

Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1676878

An immunohistological study of metastatic adenocarcinoma of the lymph node: is it useful in diagnosing a primary tumor?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1676878

A CA125 score as a prognostic index in patients with ovarian cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1676878

Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1676878

Does t-PA have a role in the treatment of crescentic glomerulonephritis?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1676878

Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1676878

Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1676878

Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential

13 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8461645

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterization

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8461645

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/8461645

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.306.6873.295

1 reference

7 August 2017

1 reference

7 August 2017

1 reference